Injection with interleukin-4-secreting fibroblasts efficiently induces T helper type 2 cell-dominated immune response

Tae Sung Kim, Seung H. Kim, Seung Y. Hwang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

To determine whether the paracrine secretion of interleukin-4 (IL-4) can efficiently induce T helper type 2 (Th2) cell-dominated immune response, BLK fibroblasts were stably transfected to secrete IL-4 (750 units/10 6 cells/48 h). Their effects on T helper cell-mediated immune response were investigated in ovalbumin (OVA)-primed C57BL/6 mice, and were compared with those of free recombinant IL-4. Injection with IL-4-secreting fibroblasts (BLK/IL-4) significantly increased anti-OVA IgG1 production in OVA-primed mice. In addition, the BLK/IL-4 cells were more effective than free recombinant IL-4 in decreasing OVA-specific IFN-γ production and in increasing OVA-specific IL-4 production by splenic CD4 + T cells. This work suggests that IL-4- secreting fibroblasts can efficiently induce Th2 cell-dominated immune response and may be beneficial in the treatment of diseases caused by undesired Th1 cell-dominated responses. (C) 2000 Elsevier Science Ltd.

Original languageEnglish
Pages (from-to)2832-2837
Number of pages6
JournalVaccine
Volume18
Issue number25
Publication statusPublished - 2000 Jun 15
Externally publishedYes

Fingerprint

Th2 Cells
interleukin-4
Interleukin-4
fibroblasts
Fibroblasts
immune response
injection
ovalbumin
Ovalbumin
Injections
cells
T-lymphocytes
Th1 Cells
mice
Helper-Inducer T-Lymphocytes
Inbred C57BL Mouse
cell-mediated immunity
Immunoglobulin G
secretion
T-Lymphocytes

Keywords

  • Fibroblast
  • Interleukin-4
  • Ovalbumin
  • T helper cell

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Injection with interleukin-4-secreting fibroblasts efficiently induces T helper type 2 cell-dominated immune response. / Kim, Tae Sung; Kim, Seung H.; Hwang, Seung Y.

In: Vaccine, Vol. 18, No. 25, 15.06.2000, p. 2832-2837.

Research output: Contribution to journalArticle

@article{3f96b32f80fb43c8a25d8b91148fd7f2,
title = "Injection with interleukin-4-secreting fibroblasts efficiently induces T helper type 2 cell-dominated immune response",
abstract = "To determine whether the paracrine secretion of interleukin-4 (IL-4) can efficiently induce T helper type 2 (Th2) cell-dominated immune response, BLK fibroblasts were stably transfected to secrete IL-4 (750 units/10 6 cells/48 h). Their effects on T helper cell-mediated immune response were investigated in ovalbumin (OVA)-primed C57BL/6 mice, and were compared with those of free recombinant IL-4. Injection with IL-4-secreting fibroblasts (BLK/IL-4) significantly increased anti-OVA IgG1 production in OVA-primed mice. In addition, the BLK/IL-4 cells were more effective than free recombinant IL-4 in decreasing OVA-specific IFN-γ production and in increasing OVA-specific IL-4 production by splenic CD4 + T cells. This work suggests that IL-4- secreting fibroblasts can efficiently induce Th2 cell-dominated immune response and may be beneficial in the treatment of diseases caused by undesired Th1 cell-dominated responses. (C) 2000 Elsevier Science Ltd.",
keywords = "Fibroblast, Interleukin-4, Ovalbumin, T helper cell",
author = "Kim, {Tae Sung} and Kim, {Seung H.} and Hwang, {Seung Y.}",
year = "2000",
month = "6",
day = "15",
language = "English",
volume = "18",
pages = "2832--2837",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "25",

}

TY - JOUR

T1 - Injection with interleukin-4-secreting fibroblasts efficiently induces T helper type 2 cell-dominated immune response

AU - Kim, Tae Sung

AU - Kim, Seung H.

AU - Hwang, Seung Y.

PY - 2000/6/15

Y1 - 2000/6/15

N2 - To determine whether the paracrine secretion of interleukin-4 (IL-4) can efficiently induce T helper type 2 (Th2) cell-dominated immune response, BLK fibroblasts were stably transfected to secrete IL-4 (750 units/10 6 cells/48 h). Their effects on T helper cell-mediated immune response were investigated in ovalbumin (OVA)-primed C57BL/6 mice, and were compared with those of free recombinant IL-4. Injection with IL-4-secreting fibroblasts (BLK/IL-4) significantly increased anti-OVA IgG1 production in OVA-primed mice. In addition, the BLK/IL-4 cells were more effective than free recombinant IL-4 in decreasing OVA-specific IFN-γ production and in increasing OVA-specific IL-4 production by splenic CD4 + T cells. This work suggests that IL-4- secreting fibroblasts can efficiently induce Th2 cell-dominated immune response and may be beneficial in the treatment of diseases caused by undesired Th1 cell-dominated responses. (C) 2000 Elsevier Science Ltd.

AB - To determine whether the paracrine secretion of interleukin-4 (IL-4) can efficiently induce T helper type 2 (Th2) cell-dominated immune response, BLK fibroblasts were stably transfected to secrete IL-4 (750 units/10 6 cells/48 h). Their effects on T helper cell-mediated immune response were investigated in ovalbumin (OVA)-primed C57BL/6 mice, and were compared with those of free recombinant IL-4. Injection with IL-4-secreting fibroblasts (BLK/IL-4) significantly increased anti-OVA IgG1 production in OVA-primed mice. In addition, the BLK/IL-4 cells were more effective than free recombinant IL-4 in decreasing OVA-specific IFN-γ production and in increasing OVA-specific IL-4 production by splenic CD4 + T cells. This work suggests that IL-4- secreting fibroblasts can efficiently induce Th2 cell-dominated immune response and may be beneficial in the treatment of diseases caused by undesired Th1 cell-dominated responses. (C) 2000 Elsevier Science Ltd.

KW - Fibroblast

KW - Interleukin-4

KW - Ovalbumin

KW - T helper cell

UR - http://www.scopus.com/inward/record.url?scp=0034659991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034659991&partnerID=8YFLogxK

M3 - Article

C2 - 10812226

AN - SCOPUS:0034659991

VL - 18

SP - 2832

EP - 2837

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 25

ER -